These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7912194)

  • 1. The alpha 2-adrenoceptor antagonist Org 3770 enhances serotonin transmission in vivo.
    De Boer T; Nefkens F; Van Helvoirt A
    Eur J Pharmacol; 1994 Feb; 253(1-2):R5-6. PubMed ID: 7912194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan.
    de Boer TH; Nefkens F; van Helvoirt A; van Delft AM
    J Pharmacol Exp Ther; 1996 May; 277(2):852-60. PubMed ID: 8627567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission.
    Haddjeri N; Blier P; de Montigny C
    J Affect Disord; 1998 Dec; 51(3):255-66. PubMed ID: 10333981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the antidepressant mirtazapine with alpha2-adrenoceptors modulating the release of 5-HT in different rat brain regions in vivo.
    Bengtsson HJ; Kele J; Johansson J; Hjorth S
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):406-12. PubMed ID: 11111835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term treatment with the alpha 2-adrenoceptor antagonist mirtazapine on 5-HT neurotransmission.
    Haddjeri N; Blier P; de Montigny C
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):20-9. PubMed ID: 9007838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacologic profile of mirtazapine.
    de Boer T
    J Clin Psychiatry; 1996; 57 Suppl 4():19-25. PubMed ID: 8636062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the alpha-2 adrenoceptor antagonist mirtazapine on the 5-hydroxytryptamine system in the rat brain.
    Haddjeri N; Blier P; de Montigny C
    J Pharmacol Exp Ther; 1996 May; 277(2):861-71. PubMed ID: 8627568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram.
    Millan MJ; Gobert A; Rivet JM; Adhumeau-Auclair A; Cussac D; Newman-Tancredi A; Dekeyne A; Nicolas JP; Lejeune F
    Eur J Neurosci; 2000 Mar; 12(3):1079-95. PubMed ID: 10762339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha 2-autoreceptors and alpha 2-heteroreceptors modulating tyrosine and tryptophan hydroxylase activity in the rat brain in vivo: an investigation into the alpha 2-adrenoceptor subtypes.
    Esteban S; Lladó J; García-Sevilla JA
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):391-9. PubMed ID: 8935705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapine.
    Haddjeri N; Blier P; de Montigny C
    Int Clin Psychopharmacol; 1995 Dec; 10 Suppl 4():11-7. PubMed ID: 8930005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission.
    de Boer T
    Int Clin Psychopharmacol; 1995 Dec; 10 Suppl 4():19-23. PubMed ID: 8930006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers.
    de Boer TH; Maura G; Raiteri M; de Vos CJ; Wieringa J; Pinder RM
    Neuropharmacology; 1988 Apr; 27(4):399-408. PubMed ID: 3419539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha 2-adrenoceptor modulation of rat ventral hippocampal 5-hydroxytryptamine release in vivo.
    Tao R; Hjorth S
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):137-43. PubMed ID: 1349158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination of mirtazapine and milnacipran augments the extracellular levels of monoamines in the rat brain.
    Yamauchi M; Imanishi T; Koyama T
    Neuropharmacology; 2012 Jun; 62(7):2278-87. PubMed ID: 22342987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological testing of 1,2,3,4,10,14b-hexahydro-6-methoxy-2-methyldibenzo[c,f]pyrazino[1,2-a]azepin and its enantiomers in comparison with the two antidepressants mianserin and mirtazapine.
    Wikström HV; Mensonides-Harsema MM; Cremers TI; Moltzen EK; Arnt J
    J Med Chem; 2002 Jul; 45(15):3280-5. PubMed ID: 12109911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation.
    Nakayama K; Sakurai T; Katsu H
    Brain Res Bull; 2004 Apr; 63(3):237-41. PubMed ID: 15145142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different actions for acute and chronic administration of mirtazapine on serotonergic transmission associated with raphe nuclei and their innervation cortical regions.
    Yamamura S; Abe M; Nakagawa M; Ochi S; Ueno S; Okada M
    Neuropharmacology; 2011 Mar; 60(4):550-60. PubMed ID: 21195096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative stimulus properties of the atypical antidepressant, mirtazapine, in rats: a pharmacological characterization.
    Dekeyne A; Millan MJ
    Psychopharmacology (Berl); 2009 Apr; 203(2):329-41. PubMed ID: 18709360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of repeated treatment with mirtazapine on the central alpha1-adrenergic receptors.
    Rogoz Z; Wrobel A; Dlaboga D; Maj J; Dziedzicka-Wasylewska M
    J Physiol Pharmacol; 2002 Mar; 53(1):105-16. PubMed ID: 11939713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential mechanisms underlie the regulation of serotonergic transmission in the dorsal and median raphe nuclei by mirtazapine: a dual probe microdialysis study.
    Fukuyama K; Tanahashi S; Hamaguchi T; Nakagawa M; Shiroyama T; Motomura E; Okada M
    Psychopharmacology (Berl); 2013 Oct; 229(4):617-26. PubMed ID: 23657423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.